MedTrace Logo

Low-dose Iron Supplementation in Non-anaemic Iron-deficient Women

NCT05869422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2025-06-11

No results posted yet for this study

Summary

The goal of this study is to investigate the efficacy of a low dose iron supplement (6mg) compared to a placebo tablet.

Conditions

  • Iron Deficiency (Without Anemia)

Interventions

DIETARY_SUPPLEMENT

Iron

60 ± 5 days of daily oral iron supplementation.

OTHER

Placebo

60 ± 5 days of daily oral placebo intake.

Sponsors & Collaborators

  • Dr. Krayenbühl GmbH

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-06
Primary Completion
2024-12-21
Completion
2024-12-21

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05869422 on ClinicalTrials.gov